The KFF 2025 Employer Health Benefits Survey provides the most granular picture to date: 43% of firms with 5,000+ workers cover GLP-1s for weight loss (up from 28% in 2024), while 30% of firms with 1,0004,999 workers and 16% of firms with 200999 workers do so ( [6] )
Perform a comprehensive assessment of the patients risk factors, including obesity/overweight, hypertension, dyslipidemia, smoking history, family history of premature coronary disease, chronic kidney disease (CKD), and presence of albuminuria
1 2 "Redox regulation of enzymes involved in sulfate assimilation and in the synthesis of sulfur-containing amino acids and glutathione in plants"
Consistency and length: trial results peaked near 26 weeks, not 4